Search Results for The Science Olympiads
LEO Foundation Award winner presented at ceremony in Antwerp
…team and I are passionate about science and dermatology and we will continue to perform translational research with meaningful impact for patients with inflammatory skin diseases.” Thierry Nordmann is recognized…
How we work
…We report on targets in our annual report. We have pledged to promote gender balance within health science and strive to do our part in supporting a research community that…
Six new Serendipity grants awarded to advance unexpected discoveries from skin research
…instead encourages bold exploration that could open entirely new directions within the life sciences. “These projects highlight the power of curiosity-driven science and the importance of supporting ideas that lie…
“We wish to support the transformation of scientific discoveries into benefits for people living with skin diseases”
…five strategic tracks are: Excellence, Nurture, Collaboration, Pioneering and Innovation. Excellence is about continuing to support outstanding science globally. Through the Nurture track, we focus both on addressing unmet needs…
Your Amazing Skin (Din fantastiske hud)
Grantee: Anne Kathrine B. Nielsen, Caretoons ApS
Amount: DKK 989,207
Grant category: Education and Awareness Grants
Year: 2025
Geography: Denmark
This is an educational project for children aged 7-12, focused on the skin and its role as the body’s largest organ, its health, and common conditions. The cross-media initiative will create an illustrated tactile book which is developed into an e-book and audiobook, as well as podcasts, animations, and a small game, which are all interconnected and offer different ways of exploring and learning. The goal is to build children’s health literacy and stimulate their curiosity for science and understanding of skin biology. Target groups include children, parents, teachers, and venues such as libraries, science centers, and museums.
New Association Secures Strong Foundation for Innovation District Copenhagen
…such as life sciences and quantum technology. A broad coalition of partners is now establishing an association to support the long-term and sustainable development of the district. The association is…
Ownership
…research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma headquarters Visit LEO Pharma The LEO Group The LEO…
Excellence in wound healing leads to the LEO Foundation Award
…Landén the LEO Foundation Award in recognition of her outstanding research. She is a highly skilled, passionate and productive young scientist with major accomplishments that will positively impact future science.”…
The LEO Foundation Award 2019 – Region Americas
…Department of Developmental and Cell Biology, School of Biological Sciences, University of California, Irvine, USA. He receives 100,000 USD for his research in skin stem cells and regeneration. The LEO…
Full thickness skin models from human pluripotent stem cells for identification and testing effectiveness of personalised therapies in atopic dermatitis
Grantee: Dr Dusko Ilic, MD, PhD, Reader in Stem Cell Sciences, Kings College London, Dr Reiko Tanaka, Lecturer, Department of Bioengineering, Imperial College, London, Dr Patrick Harrison, Senior Lecturer, Department of Physiology, University College Cork, Ireland, and Professor Theodora Mauro, MD, Professor of Dermatology, San Francisco Veterans Affairs Medical Center, USA
Amount: DKK 9,980,000
Grant category: Research Grants
Year: 2016
Geography: Ireland, United Kingdom, USA
This is an exciting project that, with the international group’s extensive research and know-how in mind, has the potential to create an intriguing base for novel personalised treatments for atopic dermatitis (AD). The project moreover holds an innovation potential that may make it stand out in the emerging global bio-economy.
The prevalence of AD, an inflammatory skin disease resulting in itchy, red, swollen and cracked skin, is constantly increasing. Today, it affects 15-30 percent children and 2-10 percent adults worldwide, presenting a significant economic burden to healthcare systems.
There is no cure for AD, only soothing of the symptoms. In the majority of AD patients, the disease is a consequence of a blend of genetic defects of the skin barrier defects and abnormal immune responses influenced by environmental factors.
Until now, the models used to assess the interplay are not particularly predictive. The group behind this project aims to change this by using the latest advances in stem cell science, gene editing and tissue engineering to develop and validate innovative 3D in vitro models of skin – making the models similar to skin in AD patients by emulating full thickness skin of varying barrier integrity; faulty, partially repaired or intact, and immune response composition.
As part of the project, the group will also develop mathematical computer models to accurately address the predictive, prognostic and therapeutic outcome of personalised AD therapy – in order to address co-dependence of the quantitative and qualitative changes in skin barrier and activation of immune cells.
The 3D models will also be made available to test various novel therapeutic approaches for AD treatment in a patient specific manner.